JP2013521288A5 - - Google Patents

Download PDF

Info

Publication number
JP2013521288A5
JP2013521288A5 JP2012556126A JP2012556126A JP2013521288A5 JP 2013521288 A5 JP2013521288 A5 JP 2013521288A5 JP 2012556126 A JP2012556126 A JP 2012556126A JP 2012556126 A JP2012556126 A JP 2012556126A JP 2013521288 A5 JP2013521288 A5 JP 2013521288A5
Authority
JP
Japan
Prior art keywords
hydroxy
aryl
alkyl
heterocyclyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012556126A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013521288A (ja
JP5937971B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/026424 external-priority patent/WO2011109267A1/en
Publication of JP2013521288A publication Critical patent/JP2013521288A/ja
Publication of JP2013521288A5 publication Critical patent/JP2013521288A5/ja
Application granted granted Critical
Publication of JP5937971B2 publication Critical patent/JP5937971B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012556126A 2010-03-04 2011-02-28 カテコールo−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用 Expired - Fee Related JP5937971B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31038610P 2010-03-04 2010-03-04
US61/310,386 2010-03-04
PCT/US2011/026424 WO2011109267A1 (en) 2010-03-04 2011-02-28 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders

Publications (3)

Publication Number Publication Date
JP2013521288A JP2013521288A (ja) 2013-06-10
JP2013521288A5 true JP2013521288A5 (enExample) 2014-04-17
JP5937971B2 JP5937971B2 (ja) 2016-06-22

Family

ID=44542514

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012556126A Expired - Fee Related JP5937971B2 (ja) 2010-03-04 2011-02-28 カテコールo−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用

Country Status (17)

Country Link
US (1) US8969364B2 (enExample)
EP (1) EP2542084B1 (enExample)
JP (1) JP5937971B2 (enExample)
KR (1) KR101761963B1 (enExample)
CN (1) CN102858177B (enExample)
AU (1) AU2011223888B2 (enExample)
BR (1) BR112012021656A2 (enExample)
CA (1) CA2789475C (enExample)
DK (1) DK2542084T3 (enExample)
ES (1) ES2662332T3 (enExample)
HU (1) HUE036431T2 (enExample)
MX (1) MX336711B (enExample)
NO (1) NO2542084T3 (enExample)
PL (1) PL2542084T3 (enExample)
PT (1) PT2542084T (enExample)
RU (1) RU2572624C2 (enExample)
WO (1) WO2011109267A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
AP2014007637A0 (en) 2011-11-15 2014-05-31 Takeda Pharmaceutical Dihydroxy aromatic heterocyclic compound
TWI638802B (zh) 2012-05-24 2018-10-21 芬蘭商奧利安公司 兒茶酚o-甲基轉移酶活性抑制化合物
US9434695B2 (en) 2012-07-18 2016-09-06 Sunshine Lake Pharma Co., Ltd Nitrogenous heterocyclic derivatives and their application in drugs
WO2014043252A2 (en) * 2012-09-11 2014-03-20 Rutgers, The State University Of New Jersey Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
EP2938600B1 (en) 2012-12-27 2017-01-25 F. Hoffmann-La Roche AG Comt inhibitors
PE20160664A1 (es) 2013-06-27 2016-07-09 Pfizer Compuestos heteroaromaticos y su uso como ligandos d1 de dopamina
JP6454348B2 (ja) 2013-12-19 2019-01-16 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. 窒素複素環誘導体およびその医薬品への応用
PL236355B1 (pl) 2015-04-02 2021-01-11 Celon Pharma Spolka Akcyjna Pochodne 7-(morfolin-4-ylo)pirazolo[1,5-α]pirymidyny jako inhibitory kinazy PI3
US10272093B2 (en) * 2015-06-08 2019-04-30 Regents Of The University Of California Use of H3K9me3 modulation for enhancing cognitive function
CA3116141C (en) 2018-12-06 2023-09-05 Daiichi Sankyo Company, Limited Cycloalkane-1,3-diamine derivative
CN113499525A (zh) * 2021-08-25 2021-10-15 骆艳 一种针对发展性阅读障碍儿童的训练系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3631045A (en) * 1969-11-04 1971-12-28 American Home Prod 4 5-diamino-7h-pyrrolo(2 3-d)pyrimidine derivatives
US3910913A (en) * 1969-11-04 1975-10-07 American Home Prod 4,5-Diamino-7H-pyrrolo{8 2,3-d{9 pyrimidine derivatives
DOP1981004033A (es) * 1980-12-23 1990-12-29 Ciba Geigy Ag Procedimiento para proteger plantas de cultivo de la accion fitotoxica de herbicidas.
US5726124A (en) * 1992-07-17 1998-03-10 Rohm And Haas Company 2-arylpyrimidines and herbicidal use thereof
CA2416248A1 (en) * 2000-07-18 2002-01-24 Neurogen Corporation 5-substituted 2-aryl-4-pyrimidinones
SE0004053D0 (sv) * 2000-11-06 2000-11-06 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
DE122009000048I1 (de) * 2001-10-26 2010-04-08 Angeletti P Ist Richerche Bio N-substituierte hydroxypyrimidinoncarboxamid-hemmer der hiv-integrase
US7166595B2 (en) * 2002-05-09 2007-01-23 Cytokinetics, Inc. Compounds, methods and compositions
US6930117B2 (en) 2002-11-09 2005-08-16 The Procter & Gamble Company N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
WO2005047268A2 (en) 2003-11-10 2005-05-26 X-Ceptor Therapeutics, Inc. Substituted pyrimidine compositions and methods of use
TW200526635A (en) * 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
GB0515327D0 (en) * 2005-07-26 2005-08-31 Portela & Ca Sa Comt inhibitors
JP2009007273A (ja) * 2007-06-27 2009-01-15 Ajinomoto Co Inc ジアミノピリミジン化合物の製造方法
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途
JP5442852B2 (ja) * 2009-08-13 2014-03-12 田辺三菱製薬株式会社 タウプロテインキナーゼ1阻害剤としてのピリミドン誘導体
WO2012151567A1 (en) * 2011-05-05 2012-11-08 St. Jude Children's Research Hospital Pyrimidinone compounds and methods for preventing and treating influenza

Similar Documents

Publication Publication Date Title
RU2012142171A (ru) Ингибиторы катехол-о-метилтрансферазы и их применение в лечении психических расстройств
JP2013521286A5 (enExample)
JP2012521428A5 (enExample)
RU2012142180A (ru) Ингибиторы катехол-о-метилтрансферазы и их применение для лечения психотических расстройств
JP2013521285A5 (enExample)
JP2015503507A5 (enExample)
RU2012142194A (ru) Ингибиторы катехол-о-метилтрансферазы и их применение при лечении психотических расстройств
JP2014526500A5 (enExample)
US20140011798A1 (en) Imidazopyrrolidinone compounds
JP2019512535A5 (enExample)
JP2016164184A5 (enExample)
JP2010523556A5 (enExample)
RU2008134423A (ru) Новые производные пиридина
JP2017537960A5 (enExample)
JP2017505762A5 (enExample)
JP2012525431A5 (enExample)
JP2013519724A5 (enExample)
MX2007014377A (es) Inhibidores de proteina cinasa de derivados de pirrol (2,3-b) piridina.
JP2016516699A5 (enExample)
JP2011528658A5 (enExample)
JP2014505107A5 (enExample)
JP2019512533A5 (enExample)
JP2014502988A5 (enExample)
JP2013540712A5 (enExample)
JP2017500321A5 (enExample)